協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/10/04 | 1,981 | 2,001 | 1,948 | 1,989 | -14 | -0.7% | 1,408,500 |
2019/10/03 | 2,009 | 2,020 | 1,994 | 2,003 | -42 | -2.1% | 1,358,000 |
2019/10/02 | 2,049 | 2,073 | 2,039 | 2,045 | -25 | -1.2% | 1,602,900 |
2019/10/01 | 2,084 | 2,089 | 2,065 | 2,070 | -28 | -1.3% | 1,671,800 |
2019/09/30 | 2,097 | 2,119 | 2,074 | 2,098 | -44 | -2.1% | 1,901,400 |
2019/09/27 | 2,142 | 2,153 | 2,112 | 2,142 | -8 | -0.4% | 1,387,500 |
2019/09/26 | 2,190 | 2,202 | 2,143 | 2,150 | -51 | -2.3% | 1,734,100 |
2019/09/25 | 2,189 | 2,210 | 2,175 | 2,201 | +29 | +1.3% | 1,510,300 |
2019/09/24 | 2,145 | 2,175 | 2,142 | 2,172 | +28 | +1.3% | 1,067,900 |
2019/09/20 | 2,112 | 2,150 | 2,101 | 2,144 | +31 | +1.5% | 2,301,500 |
2019/09/19 | 2,098 | 2,130 | 2,090 | 2,113 | +33 | +1.6% | 2,056,600 |
2019/09/18 | 2,099 | 2,103 | 2,077 | 2,080 | -20 | -1% | 1,828,100 |
2019/09/17 | 2,085 | 2,117 | 2,059 | 2,100 | +45 | +2.2% | 1,678,900 |
2019/09/13 | 2,047 | 2,060 | 2,030 | 2,055 | +35 | +1.7% | 2,398,300 |
2019/09/12 | 1,990 | 2,038 | 1,988 | 2,020 | +60 | +3.1% | 1,682,400 |
2019/09/11 | 1,985 | 1,986 | 1,953 | 1,960 | -18 | -0.9% | 1,776,900 |
2019/09/10 | 2,020 | 2,033 | 1,975 | 1,978 | -42 | -2.1% | 1,163,200 |
2019/09/09 | 1,996 | 2,021 | 1,992 | 2,020 | +34 | +1.7% | 819,200 |
2019/09/06 | 1,980 | 1,992 | 1,961 | 1,986 | +19 | +1% | 1,338,000 |
2019/09/05 | 1,981 | 1,985 | 1,956 | 1,967 | -34 | -1.7% | 1,734,200 |
2019/09/04 | 1,945 | 2,006 | 1,943 | 2,001 | +70 | +3.6% | 1,581,100 |
2019/09/03 | 1,923 | 1,938 | 1,909 | 1,931 | -2 | -0.1% | 842,000 |
2019/09/02 | 1,940 | 1,946 | 1,933 | 1,933 | -12 | -0.6% | 870,200 |
2019/08/30 | 1,924 | 1,951 | 1,910 | 1,945 | +26 | +1.4% | 2,063,500 |
2019/08/29 | 1,918 | 1,927 | 1,903 | 1,919 | +10 | +0.5% | 1,397,600 |
2019/08/28 | 1,920 | 1,952 | 1,905 | 1,909 | +56 | +3% | 2,295,100 |
2019/08/27 | 1,829 | 1,855 | 1,827 | 1,853 | +33 | +1.8% | 946,400 |
2019/08/26 | 1,773 | 1,829 | 1,772 | 1,820 | -17 | -0.9% | 1,163,200 |
2019/08/23 | 1,860 | 1,873 | 1,827 | 1,837 | -17 | -0.9% | 808,700 |
2019/08/22 | 1,854 | 1,857 | 1,831 | 1,854 | +6 | +0.3% | 1,002,500 |
2019/08/21 | 1,855 | 1,865 | 1,846 | 1,848 | -20 | -1.1% | 1,095,200 |
2019/08/20 | 1,833 | 1,868 | 1,825 | 1,868 | +51 | +2.8% | 964,800 |
2019/08/19 | 1,848 | 1,849 | 1,813 | 1,817 | +1 | +0.1% | 749,400 |
2019/08/16 | 1,803 | 1,832 | 1,802 | 1,816 | +16 | +0.9% | 1,715,500 |
2019/08/15 | 1,758 | 1,807 | 1,746 | 1,800 | +11 | +0.6% | 1,237,300 |
2019/08/14 | 1,818 | 1,827 | 1,776 | 1,789 | -4 | -0.2% | 1,128,000 |
2019/08/13 | 1,855 | 1,855 | 1,789 | 1,793 | -32 | -1.8% | 1,196,600 |
2019/08/09 | 1,836 | 1,851 | 1,823 | 1,825 | +29 | +1.6% | 1,728,400 |
2019/08/08 | 1,796 | 1,815 | 1,786 | 1,796 | +17 | +1% | 1,040,700 |
2019/08/07 | 1,734 | 1,788 | 1,733 | 1,779 | +47 | +2.7% | 1,476,200 |
2019/08/06 | 1,678 | 1,736 | 1,674 | 1,732 | +3 | +0.2% | 1,036,500 |
2019/08/05 | 1,752 | 1,753 | 1,692 | 1,729 | -48 | -2.7% | 2,376,800 |
2019/08/02 | 1,819 | 1,849 | 1,770 | 1,777 | -55 | -3% | 2,420,800 |
2019/08/01 | 1,786 | 1,836 | 1,772 | 1,832 | +29 | +1.6% | 1,436,300 |
2019/07/31 | 1,790 | 1,814 | 1,784 | 1,803 | -7 | -0.4% | 1,387,400 |
2019/07/30 | 1,811 | 1,819 | 1,802 | 1,810 | +34 | +1.9% | 3,251,000 |
2019/07/29 | 1,792 | 1,798 | 1,760 | 1,776 | -2 | -0.1% | 1,669,500 |
2019/07/26 | 1,765 | 1,783 | 1,759 | 1,778 | +4 | +0.2% | 1,037,700 |
2019/07/25 | 1,803 | 1,813 | 1,773 | 1,774 | -37 | -2% | 1,270,400 |
2019/07/24 | 1,813 | 1,818 | 1,805 | 1,811 | -10 | -0.5% | 1,124,600 |
1251~
1300
件表示中 / 3581件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 257,000円 | +11.3% | -5.4% | 2.26% | 19.78倍 | 1.56倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
塩野義 | 214,000円 | +5.7% | +3.9% | 2.68% | 10.65倍 | 1.41倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 502,900円 | +1.7% | -2.9% | 3.18% | 32.99倍 | 1.73倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 181,500円 | -3.5% | -50.2% | 4.41% | 14.70倍 | 1.09倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 274,400円 | +18.2% | +4.2% | 1.20% | 19.45倍 | 2.48倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
市場注目の銘柄
チャート関連のコラム